In order to be eligible to participate in this study, a subject must meet all of the following criteria:
Minimum age of 18 years old
Pregnant patients with a gestational age between 32+0 and 36+6 weeks and days
Singleton pregnancy
Any indication for fetal monitoring at least twice per week (e.g.):
* Pre-eclampsia (PE)
* Fetal growth restriction (FGR)
* Preterm pre-labor rupture of membranes (PPROM)
You may not be if
Oral and written informed consent is obtained.
A potential subject who meets any of the following criteria will be excluded from participation in this study:
An indication for intravenous medication
Blood pressure \>160/110 A millimeter of mercury (mmHg)
Absent-/or reversed flow umbilical artery Doppler
Hemolysis Elevated Liver enzymes and Low Platelets (HELLP) (Table 1)
Obstetric intervention expected \<48 hours, e.g. due to:
* Non reassuring cardiotocography (CTG)
* Active vaginal blood loss
* Signs of abruption placentae
* Meconium stained amniotic fluid
* Signs of chorioamnionitis
Patients admitted with a clinical diagnosis of sepsis with hypotension (i.e. septic shock).
Insufficient knowledge of Dutch or English language
Insufficient comprehension of instruction Nemo Remote® or patient information
Fetal and/or maternal cardiac arrhythmias
Contraindications to abdominal patch placement (dermatologic diseases of the abdomen precluding preparation of the abdomen with abrasive paper)
Patients connected to an external or implanted electrical stimulator, such as Transcutaneous Electro Neuro Stimulation (TENS) and pacemaker (because of disturbance of the electrophysiological signal).
